ER van Wering

2.5k citations

17 papers · 1.7k indexed · h-index 17

Impact in

Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Public Health, Environmental and Occupational Health top 1%
- Acute Lymphoblastic Leukemia research

Papers in

Hematology 6
- Chronic Myeloid Leukemia Treatments 4
- Acute Myeloid Leukemia Research 3
Public Health, Environmental and Occupational Health 15
- Acute Lymphoblastic Leukemia research 15

Co-authors: Jacques J. M. van Dongen A. Veerman K. Hählen Gertjan J.L. Kaspers Auke Beishuizen Herbert Hooijkaas CE van der Schoot MJ Willemse
Journals: Leukemia (12 papers)Blood (4 papers)British Journal of Cancer (1 paper)
Partner nations: Netherlands Portugal Spain

In The Last Decade

ER van Wering

17 papers receiving 1.7k citations

Peers

Countries citing papers authored by ER van Wering

Since Specialization

Citations

This map shows the geographic impact of ER van Wering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ER van Wering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ER van Wering more than expected).

Fields of papers citing papers by ER van Wering

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ER van Wering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ER van Wering. The network helps show where ER van Wering may publish in the future.

Co-authorship network

The 25 scholars most cited alongside ER van Wering, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with ER van Wering Line = papers co-authored together ER van Wering links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991–1996) Leukemia ·Jeffrey C. Chung, J.P.M. Bökkerink, Lucia Jančulová, A. Veerman, Lida Tzachani, ER van Wering, P.Amarjargal, J. Hermans, R Släter, Eva van den Berg, Małgorzata Migacz, A van der Does-van den Berg	2002	100
2	Immunoglobulin light chain gene rearrangements display hierarchy in absence of selection for functionality in precursor-B-ALL Leukemia ·Mirjam van der Burg, G. Tortoli, Tomasz Szczepański, ER van Wering, 李璇, Jacques J. M. van Dongen	2002	19
3	Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR Leukemia ·Georgia Zachou, MJ Willemse, CE van der Schoot, K. Hählen, ER van Wering, Jacques J. M. van Dongen	2002	95
4	BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings Leukemia ·Paulo Lúcio, Giuseppe Gaipa, Ehrkesh Nurpeisov, ER van Wering, Anna Porwit‐MacDonald, Dakyoung Lee, E. Björklund, Andrea Biondi, Klarissa Almeida Silva Platero, Robert B. Churchill, María‐Belén Vídriales, A Parreira, Jacques J. M. van Dongen, Jesús F. San Miguel, (unknown)	2001	103
5	BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL) Leukemia ·Anna Porwit‐MacDonald, E. Björklund, Paulo Lúcio, Ehrkesh Nurpeisov, Joanna Mazur, A Parreira, Klarissa Almeida Silva Platero, ER van Wering, Robert B. Churchill, Giuseppe Gaipa, Andrea Biondi, Juana Ciudad, Jacques J. M. van Dongen, Jesús F. San Miguel, (unknown)	2000	85
6	Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia Leukemia ·庄雅之, MJ Willemse, Mislav Ježić, James Balcius, Francisco Lorea Hernández, Simone A. Joosten, ER van Wering, Jacques J. M. van Dongen, CE van der Schoot	2000	152
7	Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease Leukemia ·Tomasz Szczepański, Auke Beishuizen, Carolina Flota-BaÃ±uelos, K. Hählen, ER van Wering, A Madrigali, G J Tibbe, Edgar H. Guevara Noel Tyler, Jacques J. M. van Dongen	1999	126
8	Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL Leukemia ·Paulo Lúcio, A Parreira, MWM van den Beemd, Ehrkesh Nurpeisov, ER van Wering, Robert B. Churchill, Anna Porwit‐MacDonald, E. Bjorklund, Giuseppe Gaipa, Andrea Biondi, (unknown), George Janossy, Jacques J. M. van Dongen, Jesús F. San Miguel	1999	173
9	Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome Leukemia ·まなびあテラス, LA Smets, Manon Verwijs-Janssen, Annette Schlecker, K. Siemianowski, Gertjan J.L. Kaspers, ER van Wering, A van der Does-van den Berg, Jeffrey C. Chung	1999	67
10	Immunophenotypic and immunogenotypic characteristics of TCRγδ+ T cell acute lymphoblastic leukemia Leukemia ·李璇, I L Wolvers-Tettero, Klarissa Almeida Silva Platero, ER van Wering, WD Ludwig, K. Hählen, Antje Necker, Jacques J. M. van Dongen	1999	39
11	Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infants Leukemia ·R. Pieters, Monique L. den Boer, Y. Taiwo Busari, Gritta Janka, Kjeld Schmiegelow, Gertjan J.L. Kaspers, ER van Wering, A. Veerman	1998	176
12	Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease Leukemia ·Auke Beishuizen, Edgar H. Guevara Noel Tyler, Carolina Flota-BaÃ±uelos, Bina Kumari Mehta, ER van Wering, K. Hählen, M CHURRIYATUL QULUB, Sandra de Bruin-Versteeg, Herbert Hooijkaas, Jacques J. M. van Dongen	1997	56
13	Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study Blood ·Gertjan J.L. Kaspers, LA Smets, Rob Pieters, J. A. Ross, ER van Wering, A. Veerman	1995	116
14	Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis Blood ·Auke Beishuizen, Bina Kumari Mehta, ER van Wering, K. Hählen, Herbert Hooijkaas, Poetri Maharani Septiana Dewi	1994	129
15	Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-delta gene rearrangements in acute lymphoblastic leukemia Blood ·M CHURRIYATUL QULUB, IL Wolvers-Tettero, Auke Beishuizen, Bina Kumari Mehta, ER van Wering, Poetri Maharani Septiana Dewi	1993	103
16	In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood British Journal of Cancer ·Gertjan J.L. Kaspers, Rob Pieters, J. A. Ross, P. Pena, Adina Moshavi, ER van Wering, A. Veerman	1991	86
17	Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies Blood ·JJ van Dongen, M. Rafli Kurniawan, IL Wolvers-Tettero, W M Comans-Bitter, H. J. Adriaansen, Herbert Hooijkaas, ER van Wering, Cox Terhorst	1988	119

About ER van Wering

ER van Wering is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Genetics, Immunology and Oncology, having authored 17 papers that have together received 1.7k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (15 papers), CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Childhood Cancer Survivors' Quality of Life (2 papers) and Molecular Biology Techniques and Applications (2 papers). The work is most often cited by research in Hematology (1.0k citations), Public Health, Environmental and Occupational Health (1.2k citations), Genetics (278 citations), Pathology and Forensic Medicine (357 citations) and Pediatrics, Perinatology and Child Health (360 citations). ER van Wering has collaborated with scholars based in Netherlands, Portugal and Spain. Frequent co-authors include Jacques J. M. van Dongen, A. Veerman, K. Hählen, Gertjan J.L. Kaspers, Auke Beishuizen, Herbert Hooijkaas, CE van der Schoot, MJ Willemse, Rob Pieters and IL Wolvers-Tettero. Their work appears in journals such as Leukemia, Blood and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact